Writer (Palmyra)
Enterprise AI agents on Palmyra LLMs, built for regulated industries
Overview
Writer is an enterprise AI platform built on its own Palmyra models — as of July 2026, Palmyra X5 (1M-token context) has absorbed the company's older domain-specific models — aimed at regulated industries needing governance and auditability alongside generation.
Pricing
Pricing shown for reference only. These figures reflect RECATOOLS research as of 11 Jul 2026 and may be out of date or incomplete. This is not financial or purchasing advice — always confirm the current price on the provider’s official website before making any decision.
- 5 Playbooks
- 1 GB Knowledge Graph
- 3 active connectors
- No SSO / HIPAA
- SSO / SCIM / MFA
- HIPAA BAA + SOC 2 Type II
- Unlimited Knowledge Graphs
- Finance & healthcare models
Use cases
What you can produce with Writer (Palmyra)
- Compliant financial summaries and regulatory filings drafted to house style with audit trails
- HIPAA-safe clinical documentation and patient-communication drafts approved through built-in guardrails
- Brand-consistent marketing assets (emails, ads, social copy) enforced by AI-trained style guides
- Custom enterprise AI agents that automate multi-step business processes across connected data sources
- Knowledge Graph-grounded Q&A outputs with citations traceable to internal company documents
- Domain-specific model fine-tunes for healthcare or finance embedded within existing enterprise workflows
- Observability dashboards tracking agent behavior, output quality, and policy compliance across an org
ASEAN Perspective
Writer (Palmyra) in Southeast Asia
Writer opened a Singapore hub in March 2025, appointing a VP of Asia-Pacific Japan, signalling genuine regional intent — but the expansion is currently a sales and go-to-market presence rather than a data-residency commitment. Enterprises in Singapore, Malaysia, Indonesia, or the Philippines operating under PDPA or sector-specific data localisation rules (e.g. MAS TRM, OJK) should confirm whether data processing occurs in-region before deployment. Writer's HIPAA BAA and SOC 2 Type II credentials are well-regarded by ASEAN financial-services and healthcare prospects, and the Palmyra X5 multilingual support for 30+ languages provides a practical baseline for regional content workflows. Pricing in USD and enterprise-only compliance features mean ASEAN SMBs will likely find the cost-benefit less compelling than regional alternatives.
Writer earns its enterprise price tag if you're in a regulated industry. Palmyra X5's 1M-token context, the Knowledge Graph RAG layer, and a prebuilt agent library cut real integration time compared to duct-taping OpenAI's API into a governance workflow. On G2 it holds 4.3 stars across 105 reviews, with praise for brand-consistency controls and support responsiveness. As of July 2026, Writer is retiring its older domain models (palmyra-med, palmyra-fin, palmyra-creative) in favor of the single X5 flagship, which simplifies the lineup but pushes industry-specific tuning into prompting rather than a dedicated model. The real catch is the Starter plan: capped at 5 seats, no SSO, no HIPAA coverage, so any serious deployment lands in the custom-quoted Enterprise tier. Writer opened a Singapore hub in March 2025 to chase APJ demand, but published regional data-residency options for ASEAN buyers remain thin.
What people say
Five seats. That's the ceiling on Writer's self-serve Starter plan, and it's the first thing enterprise buyers run into after the 14-day trial ends. Anything beyond a small pilot — SSO, audit logs, HIPAA coverage — requires the custom-quoted Enterprise tier, where Writer doesn't publish numbers.
What you get for that price is more than a chat wrapper. Writer builds its platform around its own Palmyra models rather than reselling someone else's API, and as of July 2026 it has folded its older domain-specific models (palmyra-med, palmyra-fin, palmyra-creative) into a single Palmyra X5 flagship with a 1-million-token context window. The Knowledge Graph layer adds inline citations and retrieval grounding, which matters for the healthcare and financial-services customers Writer explicitly targets.
On G2 the platform holds 4.3 stars across 105 reviews. Users like the brand-consistency controls and how close the first-pass output lands to something usable; the recurring complaint is a steep learning curve on the more advanced agent-building features, and a tool that doesn't always anticipate what else a task will need.
Writer opened a Singapore hub in March 2025 to serve APJ demand directly, but there's no public regional data-residency program for ASEAN customers yet — worth a direct question to sales if PDPA or local data-localisation rules apply to your deployment.
Summary of public user & expert reviews, compiled by RECATOOLS.
Notable facts
- Palmyra models are named after the ancient Syrian city renowned as a crossroads of civilizations — a nod to Writer's cross-industry ambitions.
- Palmyra X5 was trained for just $1 million in GPU compute yet benchmarks close to GPT-4.1, released April 2025.
- Writer's co-founders May Habib and Waseem AlShikh previously built Qordoba, a product localization company, before pivoting to enterprise AI.
- Writer raised its $200M Series C in November 2024 with strategic backing from Salesforce Ventures, Adobe Ventures, Citi Ventures, IBM Ventures, and Workday Ventures — an unusually broad coalition of enterprise software incumbents.
Frequently asked questions
About this listing
This entry was compiled from publicly available data including Writer (Palmyra)'s official website, press releases, documentation, and reputable third-party publications. RECATOOLS is not affiliated with Writer (Palmyra) unless explicitly stated.
Third-party AI tools update their pricing, features, availability, and policies frequently. Information here may be outdated by the time you read this — we make reasonable efforts to keep listings current, but cannot guarantee absolute accuracy.
For the latest details, please refer to Writer (Palmyra) directly →
Spotted something out of date? Suggest an update →
Writer (Palmyra) in the news
More in Business & Finance
